Search Results 421-430 of 17885 for Coagulation

1. A Phase 1B Dose-escalation Study of TRC105 in Combination With Pazopanib in Patients With Advanced Soft Tissue Sarcoma - Mayo Clinic

   Deep venous thrombosis within 6 months, unless the patient is anti-coagulated without the use of warfarin for at least 2 weeks. ... Patients who have been ...

2. A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of Pegcetacoplan in Patients With TA-TMA After Hematopoietic Stem Cell Transplantation (HSCT) - Mayo Clinic

   Diagnosis of disseminated intravascular coagulation. Diagnosis of VOD. Active GI bleeding (hematemesis or hematochezia) at baseline. Body weight < 30 kg and > ...

3. A Study of Biomarker-Directed, Pembrolizumab (MK-3475) Based Combination Therapy for Advanced Non-Small Cell Lung Cancer (MK-3475-495) - Mayo Clinic

   Coagulation. International normalized ratio (INR) OR prothrombin time (PT);; Activated partial thromboplastin time (aPTT) ≤.5 × ULN unless participant is ...

4. A Study to Evaluate the Safety, Pharmacokinetics and Biodistribution of an Imaging Agent, 18F-OP-801 (18F Hydroxyl Dendrimer) in Patients With Amyotrophic Lateral Sclerosis (ALS) and Healthy Volunteers (HV) - Mayo Clinic

   Laboratory results (serum chemistry, hematology, coagulation and urinalysis) outside the normal range at Screening and Check-In and considered clinically ...

5. Interventional Pulmonology - Overview - Mayo Clinic

   Argon plasma coagulation; Balloon dilation; Bronchoalveolar lavage; Bronchoscopy; Electromagnetic navigational bronchoscopy; Endobronchial cryotherapy and ...

6. Safety of MT-401-OTS in Patients with Relapsed AML or MDS - Mayo Clinic

   Must have adequate coagulation, hepatic, renal, and cardiac function: PT/INR and PTT/aPTT < 1.3 × ULN; AST and ALT < 3 × ULN; for participants with leukemic ...

7. MOMENTUM 3 IDE Clinical Study Protocol

   ... coagulation and heparin induced thrombocytopenia; Participation in any other clinical investigation that is likely to confound study results or affect the ...

8. A Clinical Study To Test If An Investigational Treatment Called BNT326 Is Safe And Potentially Beneficial When Used Alone Or In Combination With Other Investigational Treatments Such As BNT327, For People With Advanced Malignant Tumors - Mayo Clinic

   Participants with significant risks of hemorrhage or evidence of major coagulation disorders as specified in the protocol. Cohort 1E: Have histological ...

9. Publications - Indravadan J. Patel, M.D. - Mayo Clinic

   Consensus guidelines for periprocedural management of coagulation status and hemostasis risk in percutaneous image-guided interventions. J Vasc Interv ...

10. Saroglitazar Magnesium for Treatment of Primary Biliary Cholangitis - Mayo Clinic

    coagulation disorders, or screening blood tests that, in the opinion of the. Investigator, indicate altered coagulability (e.g., PT, INR, aPTT) at screening ...